Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.54 EUR | +1.18% | +1.95% | -2.31% |
Apr. 30 | QIAGEN NV : Berenberg reaffirms its Buy rating | ZD |
Apr. 30 | QIAGEN : A decent start to 2024; guidance unchanged |
Sales 2024 * | 2.01B 1.87B | Sales 2025 * | 2.14B 2B | Capitalization | 9.5B 8.86B |
---|---|---|---|---|---|
Net income 2024 * | 407M 380M | Net income 2025 * | 450M 420M | EV / Sales 2024 * | 4.91 x |
Net Debt 2024 * | 366M 342M | Net cash position 2025 * | 116M 108M | EV / Sales 2025 * | 4.39 x |
P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
21.1
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Qiagen N.V.
1 day | +1.43% | ||
1 week | +1.68% | ||
Current month | -1.40% | ||
1 month | -1.40% | ||
3 months | -6.56% | ||
6 months | +10.29% | ||
Current year | -3.79% |
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 39.68 | +1.52% | 401 762 |
24-04-30 | 39.08 | -0.17% | 977,052 |
24-04-29 | 39.14 | +0.99% | 753,805 |
24-04-26 | 38.76 | +2.16% | 834,392 |
24-04-25 | 37.94 | -1.65% | 1,131,178 |
Delayed Quote Xetra, April 30, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- QGEN Stock
- QIA Stock